The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study

Author(s):
Loo, A.J.A.E. van de; Bervoets, A.C.; Mooren, L.; Bouwmeester, N.H.; Garssen, J.; Zuiker, R.; Amerongen, G. van; Gerven, J. van; Singh, J.; Ark, P. van der; Fedgchin, M.; Morrison, R.; Wajs, E.; Verster, J.C.
Published
2017
Publication type
Article / Letter to editor
DrivingSDLPEsketamineMirtazapineDepression
Date issued
2017-11-30
Language
English
Is part of
Psychopharmacology (2017), Vol. 234, no. 21, p. 3175-3183
hdl
1887/116422
doi
10.1007/s00213-017-4706-6